HARVARD BIOSCIENCE INC's ticker is HBIO and the CUSIP is 416906105. A total of 67 filers reported holding HARVARD BIOSCIENCE INC in Q1 2023. The put-call ratio across all filers is 0.22 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,470,603 | -22.2% | 807,117 | -0.7% | 1.89% | -14.6% |
| Q2 2023 | $4,463,447 | -5.5% | 813,014 | -27.7% | 2.21% | -17.6% |
| Q1 2023 | $4,721,665 | +149841.7% | 1,124,206 | -1.1% | 2.69% | +44.4% |
| Q4 2022 | $3,149 | -99.8% | 1,136,845 | +54.4% | 1.86% | -4.3% |
| Q3 2022 | $1,885,000 | -15.8% | 736,434 | +18.4% | 1.94% | -6.5% |
| Q2 2022 | $2,239,000 | -31.4% | 621,981 | +18.3% | 2.08% | -19.6% |
| Q1 2022 | $3,263,000 | +7.0% | 525,586 | +21.5% | 2.58% | +15.8% |
| Q4 2021 | $3,049,000 | – | 432,445 | – | 2.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AMH Equity Ltd | 2,053,907 | $8,626,409 | 9.88% |
| B. Riley Asset Management, LLC | 3,408,796 | $14,316,943 | 5.93% |
| Meros Investment Management, LP | 1,124,206 | $4,721,665 | 2.69% |
| Harvey Partners, LLC | 2,712,700 | $11,393,340 | 1.41% |
| Archon Capital Management LLC | 1,361,769 | $5,719,430 | 1.28% |
| PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. | 2,947,329 | $12,378,782 | 0.80% |
| BARD ASSOCIATES INC | 291,297 | $1,223,448 | 0.50% |
| Portolan Capital Management | 1,043,546 | $4,382,893 | 0.42% |
| HEARTLAND ADVISORS INC | 1,200,000 | $5,040,000 | 0.31% |
| EAM Investors, LLC | 345,546 | $1,451,293 | 0.28% |